Summary

Report Scope
Chronic disease management encompasses drugs and medical device-based techniques. This report can serve as an analytical business tool to evaluate the global market for therapeutics and advanced device technologies for chronic disease management.
This report analyzes market trends with data from 2023, estimates for 2024 and projections of CAGRs through 2029. It evaluates the market potential for chronic disease management and provides an analysis of the competitive landscape. The report covers the market’s drivers, restraints and opportunities, as well as the market shares of leading companies.
The market is segmented into product type, application, end user, and geographic region. Product segments include pharmaceuticals and biologics (drugs and biologics), medical devices (traditional and wearable devices) and digital therapeutics. Application areas (disease categories) are cancer, metabolic disorders, musculoskeletal disorders, cardiovascular conditions, immunological disorders, gastrointestinal disorders, respiratory diseases, neurological conditions, psychiatric conditions, and others. End users are categorized into hospitals and other facilities and home care. The global market is segmented into the regions of North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This analysis also includes broken down by country.
Report Includes
- 106 data tables and 39 additional tables
- Analyses of global market trends, with historic market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
- Estimates of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application, end user, and region
- Analysis of the market dynamics, technological advances, regulations, and the macroeconomic factors influencing the market
- A look into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support chronic disease management
- Identification of promising new drugs, biologics, and emerging device technologies still in the development and testing stages
- A look at the regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products and their potential for commercialization
- A look at the recent patent grants
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
- Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
- Profiles of market leaders, including Abbott, Bristol Myers Squibb Co., F. Hoffmann-La Roche Ltd., Pfizer Inc., and Johnson & Johnson Services Inc.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
What's New in This Update?
Market Summary
Chapter 2 Market Overview
Market Insights
Regulatory Background
Chronic Disease Management Act of 2021 (CDMA)
Regional Regulatory Frameworks for Chronic Disease Medical Devices
Regulatory Systems for Pharmaceuticals, by Region
Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices, by Region
Pricing and Reimbursement for Pharmaceuticals, by Region
Chapter 3 Market Dynamics
Overview
Market Drivers
Growing Aging Population Worldwide
Growing Prevalence of Chronic Diseases
Technological Advances
Government Initiatives and Funding
Market Restraints
High Cost of Treatments
Patent Expiry and Shorter Product Life Cycles
Regulatory Issues for Drugs, Medical Devices and Software Applications
Limited Access in Low-Income Regions
Market Challenges
Medication Nonadherence
Regulatory Challenges
Challenges with Digital Health Applications
Market Opportunities
Digital Therapeutics
Strong Research and Development Initiatives from Key Market Players
Chapter 4 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis, by Product Type
Pharmaceutical Drugs and Biologics
Medical Devices
Digital Therapeutics
Market Analysis, by Application
Oncological Diseases
Metabolic Disorders
Cardiovascular Diseases
Immunological Disorders
Respiratory Diseases
Musculoskeletal Disorders
Chronic Gastrointestinal Diseases
Neurological Diseases
Psychiatric Disorders
Other Applications
Market Analysis, by End User
Home Care
Hospitals and Others
Geographic Breakdown
Market Analysis, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 5 Emerging Trends and Technologies
Overview
Mobile Health Technology
AI, Machine Learning, and Deep Learning in Chronic Care Management
Remote Patient Monitoring Devices
Digital Therapeutics
Biowearable Technology
Glucose-Sensing Contact Lenses
Recent Approvals and Launches of Novel Drug and Device Products
Chapter 6 ESG Developments
ESG in the Chronic Disease Management Industry
ESG Risk Ratings
BCC Research Viewpoint
Chapter 7 Competitive Landscape
Mergers, Acquisitions and Collaborations
Patent Analysis
Patent Review, by Assignee Country
Patent Review, by Year
Company Share Analysis
Strategic Alliances
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AMGEN INC.
ASTRAZENECA
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
GSK PLC.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
PFIZER INC.